NAMS Financial Model

Quarterly and annual income statement, cash flow and balance sheet line items for NewAmsterdam Pharma Company N.V. Ordinary Shares: revenue, gross and operating margin, EBITDA, free cash flow, buybacks, cash, debt and shares outstanding. Latest statement: Jun 30, 2026.

NAMS – NewAmsterdam Pharma Company N.V. Ordinary Shares stock overview